Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
28
MRSN Quote, Financials, Valuation and Earnings
Last price:
$0.37
Seasonality move
:
-25.5%
Day range:
$0.32 - $0.35
52-week range:
$0.26 - $2.83
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.23x
P/B ratio:
57.95x
Volume:
1M
Avg. volume:
2.8M
1-year change:
-84.92%
Market cap:
$42.3M
Revenue:
$40.5M
EPS (TTM):
-$0.59
Earnings Data
Next earnings date for MRSN
Aug 08
2025
Most recent earnings per share
-$0.19
Beat by $0.00
(May 15/2025)
Consensus Estimate
-$0.19
(May 15/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MRSN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $6.1M | -- | -- | -$0.15 | -- |
| 08/08/2025 | Q2 | $6.1M | -- | -- | -$0.17 | -- |
| 05/15/2025 | Q1 | $6M | $2.8M | -$0.19 | -$0.19 | $0.00 |
| 03/03/2025 | Q4 | $7.7M | $16.4M | -$0.11 | -$0.17 | $0.06 |
| 11/13/2024 | Q3 | $7.6M | $12.6M | -$0.09 | -$0.19 | $0.10 |
| 08/13/2024 | Q2 | $8.7M | $2.3M | -$0.20 | -$0.18 | -$0.02 |
| 05/09/2024 | Q1 | $8.3M | $9.2M | -$0.16 | -$0.18 | $0.02 |
| 02/28/2024 | Q4 | $14.8M | $10.7M | -$0.16 | -$0.19 | $0.03 |
| 11/07/2023 | Q3 | -- | -- | -$0.35 | -$0.34 | -$0.01 |
| 08/08/2023 | Q2 | -- | -- | -$0.47 | -$0.48 | $0.01 |
| 05/09/2023 | Q1 | -- | -- | -$0.52 | -$0.48 | -$0.04 |
| 02/28/2023 | Q4 | -- | -- | -$0.44 | -$0.52 | $0.08 |
| 11/07/2022 | Q3 | -- | -- | -$0.61 | $0.06 | -$0.67 |
| 08/08/2022 | Q2 | -- | -- | -$0.55 | -$0.50 | -$0.05 |
| 05/09/2022 | Q1 | -- | -- | -$0.59 | -$0.27 | -$0.32 |
| 02/28/2022 | Q4 | -- | -- | -$0.68 | -$0.65 | -$0.03 |
| 11/09/2021 | Q3 | -- | -- | -$0.63 | -$0.57 | -$0.06 |
| 08/06/2021 | Q2 | -- | -- | -$0.59 | -$0.49 | -$0.10 |
| 05/10/2021 | Q1 | -- | -- | -$0.50 | -$0.38 | -$0.12 |
| 02/26/2021 | Q4 | -- | -- | -$0.43 | -$0.32 | -$0.11 |
| 11/09/2020 | Q3 | -- | -- | -$0.33 | -$0.30 | -$0.03 |
| 08/07/2020 | Q2 | -- | -- | -$0.33 | -$0.29 | -$0.04 |
| 05/08/2020 | Q1 | -- | -- | -$0.35 | -$0.37 | $0.02 |
| 02/28/2020 | Q4 | -- | -- | -$0.34 | -$0.38 | $0.04 |
| 11/06/2019 | Q3 | -- | -- | -$0.35 | -$0.37 | $0.02 |
| 08/08/2019 | Q2 | -- | -- | -$0.36 | -$0.39 | $0.03 |
| 05/09/2019 | Q1 | -- | -- | $0.70 | -$0.07 | $0.77 |
| 03/08/2019 | Q4 | -- | -- | -$0.97 | -$0.68 | -$0.29 |
| 11/13/2018 | Q3 | -- | -- | -$0.75 | -$0.59 | -$0.16 |
| 08/15/2018 | Q2 | -- | -- | -$0.54 | -$0.58 | $0.04 |
| 05/14/2018 | Q1 | -- | -- | -$0.54 | -$0.59 | $0.05 |
| 03/28/2018 | Q4 | -- | -- | -$0.61 | -$0.48 | -$0.13 |
| 11/09/2017 | Q3 | -- | -- | -$0.35 | -$0.43 | $0.08 |
| 08/11/2017 | Q2 | -- | -- | -$0.39 | -$0.54 | $0.15 |
Mersana Therapeutics Earnings Questions
-
How Much did Mersana Therapeutics Generate in Revenue Last Quarter?
Mersana Therapeutics reported $2.8M worth of top line sales in its most recent quarter.
-
Did Mersana Therapeutics Beat Earnings Last Quarter?
Mersana Therapeutics announced earnings per share of -$0.19 which represents a beat of analyst forecast a -$0.19 per share.
-
Is Mersana Therapeutics Profitable?
Mersana Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Mersana Therapeutics EPS Next Year?
Mersana Therapeutics's earnings are forecast to decrease from -$0.56 per share to -$0.61 per share next year representing a decrease of -6.25%.
-
When is Mersana Therapeutics's Earnings Date?
Mersana Therapeutics's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
